About Us
Terms & Conditions
Privacy Policy
FAQ
Contact Us
Careers
Advertise
Download The App
Car Sticker
Community
Copyright © BFM Media Sdn Bhd (200601017962)
Play the Live Stream or select a Podcast to play
0:00
0:00
0:00
0:00
Play the Live Stream or select a Podcast to play
0:00
0:00
0:00
0:00
ADVERTISEMENT
Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech
Morning Run · The Breakfast Grille · 13 Mar 2024 · 08:00 am · 26 mins listen
Malaysian pharmaceutical Duopharma Biotech achieved their best financial performance to date in 2022, reaching record highs for revenue and profit. However 2023 was not as kind, with profit after tax falling by 25% despite top line growth. How are they looking to reverse course in 2024? We discuss strategy with Group Managing Director Leonard Ariff Abdul Shatar.
Related Content
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
